Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Eve Palmer (Newcastle upon Tyne, United Kingdom), Eve Palmer, Nicholas Lane, John Davison, Donna McEvoy, Anthony De Soyza. Pneumococcal vaccination in bronchiectasis- an area for improvement?. Eur Respir J 2016; 48: Suppl. 60, 1558

Member's Comments

No comment yet.

Related content which might interest you: Pneumococcal vaccination Source: Eur Respir J 2005; 26: 982-983 Year: 2005 Pneumococcal and influenza vaccination Source: Eur Respir Monogr 2014; 63: 266-284 Year: 2014 Pneumococcal vaccination practices and recommendations around the world Source: International Congress 2017 – Global challenges in respiratory medicine Year: 2017 Pneumococcal polysaccharide vaccination in COPD patients - some problems with antibody-response Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 Efficacy of vaccination to prevent pneumococcal infection in organized communities Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Pneumococcal vaccination: current and future issues Source: Eur Respir J 2001; 18: 184-195 Year: 2001 Influenza and pneumococcal vaccination Source: International Congress 2017 – State of the art session: "Respiratory infections" Year: 2017 Pneumococcal vaccine: when, what, how and to whom Source: International Congress 2014 – MS06 What's new in pneumococcal vaccination? Year: 2014 Influenza and pneumococcal immunization initiates work Source: Eur Respir J 2001; 18: Suppl. 33, 207s Year: 2001 Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 Should pneumococcal vaccines be used to prevent LRTI? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine Source: Eur Respir J 2013; 42: 1595-1603 Year: 2013 Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly Source: Eur Respir J 2010; 36: 608-614 Year: 2010 Impact of the vaccination campaign on pneumococcal pneumonia after the great East Japan earthquake Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Serotype dynamics in pneumococcal diseases and the performance of vaccination strategies for older adults in germany Source: Virtual Congress 2020 – How do different treatment strategies translate into costs Year: 2020 Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013) Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014